Instem, a provider of IT solutions and services to the global life sciences market, completed the acquisition of PDS Life Sciences, a life sciences software company. Financial terms were not disclosed. “This is good news for Instem, PDS and the entire industry. For decades, both Instem and PDS have been providing innovative solutions that help organizations accelerate non-clinical development, and we have always been impressed with their highly experienced team. This acquisition will enable us to concentrate our investment into a single line of products, and we are looking forward to advancing what will be a very exciting roadmap. By combining our technologies and talents we will be able to more quickly develop and deliver solutions that provide even higher value to our clients,” Gregor Grant, Instem Executive Vice President.